qli5 therapeutics
Pioneering a breakthrough in proteasome inhibitors with unmatched selectivity and innovative, non-covalent binding properties.
1 employees · est. 2020
Totus Medicines
Making every disease treatable by making the total human genome druggable.
33 employees · est. 2020 · Emeryville, United States
Totus Medicines is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | qli5 therapeutics | Totus Medicines |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2020 |
| Headquarters | ||
| Headquarters | Not tracked yet | Emeryville, United States |
| Employees | ||
| Employees | 1 | 33 larger |
| Industry | ||
| Industry | Health and Wellness | Biopharma, Biotechnology |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $15.00M | $107.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Development of next-generation proteasome inhibitors, Research collaboration with Max Planck Institute, Platform technology for unmet medical needs | Development of precision oral medicines, Targeting undruggable disease-relevant targets, Advancement of small-molecule therapies |
| Target Customers | ||
| Target Customers | Healthcare providers, Pharmaceutical companies, Biotech researchers, Cancer treatment centers, Patients with multiple myeloma, Patients with solid tumors | Patients with limited treatment options, Healthcare providers in oncology, immunology, and inflammation sectors |
| Taxonomy | ||
| Taxonomy | Proteasome Inhibitors, Selective Inhibition, Non-Covalent Binding, Therapeutics Development, Pharmaceutical Innovation, Drug Discovery, Targeted Therapy, Oncology Research, Molecular Medicine, Advanced Biomedicine | Chemical Biology, Covalent Therapeutics, Drug Discovery, Genomic Medicine, Untreatable Diseases, Covalent Drugs, Drug Screening, Undruggable Targets, Pharmaceutical Innovation, Precision Medicine, Target Identification, Therapeutic Development |
| Website | ||
| Website | qli5tx.com | totusmedicines.com |
About qli5 therapeutics
Qli5 Therapeutics, founded in 2020, is forging new pathways in the Health and Wellness industry by developing an innovative class of proteasome inhibitors. Their approach uniquely combines high selectivity with non-covalent binding properties, setting them apart in the field. The startup's slogan,...
About Totus Medicines
Totus Medicines, founded in 2020, is an emerging leader in the Biopharma and Biotechnology sectors, headquartered in the United States. The company is committed to its bold vision of "Making every disease treatable by making the total human genome druggable." By leveraging groundbreaking chemical bi...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at qli5 therapeutics and Totus Medicines — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at qli5 therapeutics and Totus Medicines — by email.
Frequently Asked Questions
Compare qli5 therapeutics with someone else
Start typing a company name or domain.